HK77693A - Cycloalkylamides of(8beta)-1-alkyl-6-(substituted)ergolines - Google Patents

Cycloalkylamides of(8beta)-1-alkyl-6-(substituted)ergolines

Info

Publication number
HK77693A
HK77693A HK776/93A HK77693A HK77693A HK 77693 A HK77693 A HK 77693A HK 776/93 A HK776/93 A HK 776/93A HK 77693 A HK77693 A HK 77693A HK 77693 A HK77693 A HK 77693A
Authority
HK
Hong Kong
Prior art keywords
alkyl
substituted
cycloalkylamides
8beta
ergolines
Prior art date
Application number
HK776/93A
Other languages
English (en)
Inventor
Mark M Foreman
William L Garbrecht
Gifford P Marzoni
Kathleen R Whitten
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of HK77693A publication Critical patent/HK77693A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06—Lysergic acid amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Urology & Nephrology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK776/93A 1987-06-15 1993-08-05 Cycloalkylamides of(8beta)-1-alkyl-6-(substituted)ergolines HK77693A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6228587A 1987-06-15 1987-06-15

Publications (1)

Publication Number Publication Date
HK77693A true HK77693A (en) 1993-08-13

Family

ID=22041482

Family Applications (1)

Application Number Title Priority Date Filing Date
HK776/93A HK77693A (en) 1987-06-15 1993-08-05 Cycloalkylamides of(8beta)-1-alkyl-6-(substituted)ergolines

Country Status (22)

Country Link
EP (1) EP0296748B1 (fr)
JP (1) JP2653835B2 (fr)
KR (1) KR960010454B1 (fr)
CN (1) CN1019451B (fr)
AT (1) ATE87921T1 (fr)
AU (1) AU613641B2 (fr)
CA (1) CA1339661C (fr)
DE (1) DE3880022T2 (fr)
DK (1) DK322588A (fr)
EG (1) EG18586A (fr)
ES (1) ES2054806T3 (fr)
HK (1) HK77693A (fr)
HU (2) HU203344B (fr)
IE (1) IE61884B1 (fr)
IL (1) IL86725A (fr)
MX (1) MX11866A (fr)
NZ (1) NZ225022A (fr)
PH (1) PH24309A (fr)
PT (1) PT87716B (fr)
SU (1) SU1597103A3 (fr)
UA (1) UA6022A1 (fr)
ZA (1) ZA884222B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4902691A (en) * 1988-12-19 1990-02-20 Eli Lilly And Company Heteroalkylamides of (8-β)-1-alkyl-6-(substituted)ergolines useful for blocking 5HT2 receptors
IT1232692B (it) * 1989-08-04 1992-03-04 Poli Ind Chimica Spa Derivati ergolinici con attivita' dopaminergica
US5141944A (en) * 1990-04-11 1992-08-25 Eli Lilly And Company N-(2-hydroxycyclopentyl)-1-isopropyl-6-methylergoline-8-carboxamides
US5043341A (en) * 1990-04-11 1991-08-27 Eli Lilly And Company N-(2-hydroxycyclopentyl)-1-isopropyl-6-methylergoline-8-carboxamides
CA2218143A1 (fr) * 1995-04-18 1996-10-24 Eli Lilly And Company Procede d'utilisation de composes d'ergoline pour effectuer des fonctions physiologiques et pathologiques sur le recepteur 5-ht7
US5880134A (en) * 1996-03-20 1999-03-09 Eli Lilly And Company Method for using ergoline compounds to effect physiological and pathological functions at the 5-HT7 receptor
EP2053438B1 (fr) 1998-05-26 2014-04-16 Canon Kabushiki Kaisha Détecteur de mise au point, dispositif de mésure de distance et dispositif optique d'ajustement de la focalisation
EP2515654A4 (fr) 2009-12-23 2013-04-24 Map Pharmaceuticals Inc Analogues d'ergoline
CN102775402B (zh) * 2011-05-13 2015-08-26 上海现代制药股份有限公司 一种制备二氢麦角酸的中间体及其制备方法
MX2013015373A (es) 2011-06-23 2014-02-11 Map Pharmaceuticals Inc Nuevos analogos de fluoroergolina.
SG11201403434YA (en) 2011-12-19 2014-09-26 Map Pharmaceuticals Inc Novel iso-ergoline derivatives
SG10201506202RA (en) 2011-12-21 2015-09-29 Map Pharmaceuticals Inc Novel neuromodulatory compounds
US9012640B2 (en) 2012-06-22 2015-04-21 Map Pharmaceuticals, Inc. Cabergoline derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH386441A (de) * 1961-02-17 1965-01-15 Sandoz Ag Verfahren zur Herstellung von am Indolstickstoff substituierten Derivaten der Lysergsäure-Reihe
GB982737A (en) * 1961-05-08 1965-02-10 Westminster Bank Ltd Improvements in or relating to lysergic acid compounds
GB996062A (en) * 1961-07-13 1965-06-23 Westminster Bank Ltd Improvements in or relating to lysergic acid compounds

Also Published As

Publication number Publication date
KR960010454B1 (ko) 1996-08-01
SU1597103A3 (ru) 1990-09-30
UA6022A1 (uk) 1994-12-29
DK322588D0 (da) 1988-06-14
IE61884B1 (en) 1994-11-30
MX11866A (es) 1993-12-01
ATE87921T1 (de) 1993-04-15
NZ225022A (en) 1990-07-26
DK322588A (da) 1989-02-01
HU203344B (en) 1991-07-29
KR890000482A (ko) 1989-03-14
PT87716B (pt) 1992-10-30
HU211235A9 (en) 1995-11-28
PH24309A (en) 1990-05-29
AU613641B2 (en) 1991-08-08
IE881788L (en) 1988-12-15
DE3880022T2 (de) 1993-08-19
CA1339661C (fr) 1998-02-10
HUT47271A (en) 1989-02-28
JP2653835B2 (ja) 1997-09-17
JPS6416781A (en) 1989-01-20
DE3880022D1 (de) 1993-05-13
ES2054806T3 (es) 1994-08-16
CN1030586A (zh) 1989-01-25
AU1765288A (en) 1988-12-15
EP0296748B1 (fr) 1993-04-07
EG18586A (en) 1993-08-30
ZA884222B (en) 1990-02-28
IL86725A (en) 1993-01-14
PT87716A (pt) 1988-07-01
CN1019451B (zh) 1992-12-16
IL86725A0 (en) 1988-11-30
EP0296748A1 (fr) 1988-12-28

Similar Documents

Publication Publication Date Title
EG18586A (en) Cycloalkylamides of(beta,beta)-1-alkyl-6-(substituted)ergolines
ES538418A0 (es) Un derivado de indol-3-carboxamida
HK1019878A1 (en) Total synthesis of antitumor acylfulvenes.
AU591640B2 (en) Quinolonecarboxylic acid derivatives
IL114715A0 (en) Intermediate compounds for ring-substituted 2-amino - 1, 2, 3, 4-tetra-hydronaphthalenes and 3-aminochromanes
PL339143A1 (en) Tetrahydro-gamma-carbolynes
GR3021971T3 (en) Imidazonaphthyridine derivatives
EP0288969A3 (en) Antiulcer composition
IL86080A0 (en) Bicyclic compounds,processes for preparation thereof and pharmaceutical composition comprising the same
EP0192210A3 (en) New cephem compounds and processes for preparation thereof
GR3005444T3 (fr)
GR3001955T3 (en) N-phenethylaminoalkyl-benzamide anti-arrhythmia agents
EP0250814A3 (en) Prophylactic and curing composition containing a 8-chlorobenzothiazepine compound and its use
GR3033353T3 (en) Prostaglandin I analogue.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)